share_log

Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Espinoza Octavio

Ligand Pharmaceuticals | 4:持股變動聲明-首席財務官 Espinoza Octavio

SEC announcement ·  2023/12/06 15:27
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息